Matt Zuga

Insider Reports History

Entity
Individual
Location
C/O Tela Bio, Inc., 1 Great Valley Parkway, Suite 24, Malvern, PA
Signature
/s/ Jeffrey Hamet, Attorney-in-Fact for W. Matthew Zuga
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matt Zuga:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Acumen Pharmaceuticals, Inc. CFO & Chief Business Officer Common Stock 211K $734K $3.47 Jan 18, 2024 Direct
Acumen Pharmaceuticals, Inc. CFO & Chief Business Officer Employee Stock Option (right to buy) 159K Jan 2, 2024 Direct
ELUTIA INC. Director, 10%+ Owner Stock Option (Right to Buy) 31.8K Jun 6, 2024 Direct

Insider Reports Filed by Matt Zuga

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ELUT ELUTIA INC. Jun 6, 2024 1 $0 4 Jun 10, 2024 Director, 10%+ Owner
ABOS Acumen Pharmaceuticals, Inc. Jan 18, 2024 1 -$15.7K 4 Jan 19, 2024 CFO & Chief Business Officer
ABOS Acumen Pharmaceuticals, Inc. Jan 2, 2024 2 $0 4 Jan 4, 2024 CFO & Chief Business Officer
ABOS Acumen Pharmaceuticals, Inc. Jan 17, 2023 2 $0 4 Jan 18, 2023 CFO and Chief Business Officer
ABOS Acumen Pharmaceuticals, Inc. Dec 29, 2022 2 $59.5K 4 Jan 3, 2023 CFO and Chief Business Officer
ABOS Acumen Pharmaceuticals, Inc. Jan 19, 2022 1 $0 4 Jan 21, 2022 CFO and Chief Business Officer
ABOS Acumen Pharmaceuticals, Inc. Jul 6, 2021 3 $0 4 Jul 8, 2021 Chief Financial Officer
ABOS Acumen Pharmaceuticals, Inc. Jun 30, 2021 0 $0 3 Jun 30, 2021 Chief Financial Officer